Kisspeptin: Side Effects & Safety
Part of the Kisspeptin Complete Guide
Research Peptides
We may earn a commission if you purchase through this link, at no extra cost to you.
Overall Safety Profile
Kisspeptin has demonstrated a favorable safety profile in clinical studies, with no serious drug-related adverse events reported. As an endogenous neuropeptide, it benefits from biological compatibility. Its short half-life limits sustained exposure.
Reported Side Effects
- Injection site reactions: Mild, transient
- Transient hormonal changes: LH and testosterone increases are short-lived and dose-dependent
- No OHSS cases: A key safety advantage in IVF applications compared to hCG
Important Limitations
Continuous kisspeptin exposure desensitizes GnRH neurons, paradoxically suppressing reproductive hormones — pulsatile administration is essential. Long-term safety data is limited. The effects of chronic kisspeptin administration on reproductive function, bone density, and metabolic health require further study.
Potential Contraindications
- Hormone-sensitive cancers (breast, prostate)
- Precocious puberty
- Pregnancy (effects on pregnancy maintenance unknown)